Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi Arabia
Alaa Shahbar, Abdullah A Alhifany, Yasser M Alatawi, Mohammed Alnuhait, Abdullah Alshammari, Majed Alshamrani, Abdulhalim Kinsara, Atif AlQubbany, Mahasen Alharbi, Abdelmajid Alnatsheh, Meteb Alfoheidi · 2024
Read Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi Arabia by Alaa Shahbar, Abdullah A Alhifany, Yasser M Alatawi, Mohammed Alnuhait, Abdullah Alshammari, Majed Alshamrani, Abdulhalim Kinsara, Atif AlQubbany, Mahasen Alharbi, Abdelmajid Alnatsheh, Meteb Alfoheidi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11603457.txt.
Description
Alaa Shahbar and co-authors count heart harm in a 2024 study of breast cancer care in Saudi Arabia. Drugs that home on one tumor switch save lives, yet they can drop the heart pump share and tip some into heart fail. As more women live long past care, that harm must be tracked.
Files span five years of women who got at least one dose of such a drug. Harm was set by a strict mark: a low pump share with a set fall, a steep drop, or clear heart fail signs. Counts by drug and by span give the first local rate. Heart and cancer teams gain a base rate to plan checks.
Catalog record
| CREATOR | Alaa Shahbar, Abdullah A Alhifany, Yasser M Alatawi, Mohammed Alnuhait, Abdullah Alshammari, Majed Alshamrani, Abdulhalim Kinsara, Atif AlQubbany, Mahasen Alharbi, Abdelmajid Alnatsheh, Meteb Alfoheidi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |